ECP 2023 Final Programme

E-Posters 154 E-PS-15 020 Homologous recombination deficiency analysis by panel NGS in 148 penile squamous cell carcinoma samples Jan Hojný, Czech Republic M. Kendall Bártů, E. Krkavcová, R. Michálková, J. Hrudka 021 Revolution in pathology, no more formalin fixation! Reduced DNA deterioration in five years in nonfixed tissues processed with supercritical CO2 compared to formalin fixation Marije Hoogland, The Netherlands N. van der Horst, A. Knol, M. Niemantsverdriet 022 Lack of correlation of MET and PD-L1 expression in non-small cell lung cancer challenges anti-PD-1/PD-L1 and anti-MET therapeutic strategies, per a comparative study of matched biopsies and surgical resection samples Marius Ilié, France V. Hofman, C. Bontoux, S. Goffinet, J. Benzaquen, J. Boutros, S. Lassalle, E. Long-Mira, A. Gómez-Caro, C. Cohen, J. Berthet, C. Marquette, P. Hofman 023 Creation of contrived plasma samples with RNA variants to use as liquid biopsy reference material Madhuri Jasti, USA S. Hernandez, M. Chen, K. Bramlett, A. Luchetti 024 The Pathology Genomics Imaging Collection: progress on the collaboration between Genomics England and the National Pathology Imaging Cooperative Charlotte Jennings, United Kingdom M. Humphries, C. Colquhoun, D. Kaye, G. Stankeviciute, C. Chen, G. Chan, B. Selinsek, R. Chabra, L. Valis, D. Bansal, P. Arumugam, D. Westhead, D. Treanor 025 CCND1 but not DOG1 is associated with an aggressive phenotype of urothelial bladder cancer Martina Kluth, Germany A. Frericks, H. Plage, M. Lennartz, N. Blessin, M. Slojewski, T. Ecke, S. Koch, R. Simon, G. Sauter, T. Klatte, T. Schlomm, D. Horst, H. Zecha, K. Jansen 026 Tumour mutation burden analysis in solid tumours Yunus Baran Kök, Turkey S. Erdamar Çetin, M. Yakıcıer, A. Erşen Danyeli, F. Tokat, Ü. İnce 027 Homologous recombination deficiency analysis in solid tumours Yunus Baran Kök, Turkey S. Erdamar Çetin, A. Erşen Danyeli, F. Tokat, M. Yakıcıer, Ü. İnce 028 Different miRNA involvement in rectal neuroendocrine tumours showing either common mutation or high mitotic index: a pilot study Mi Jung Kwon, Korea S. Kang, H. Kang, H. Park, N. Kim, M. Hong 030 Evaluation of the expression of 148A and 192 mirRNA association with postoperative complications in patients undergoing liver transplant at Fundación Santa Fe de Bogotá Rocío Del Pilar López Panqueva, Colombia D. Grajales Urrego, P. Trujillo Morales, H. Gonzalez, R. Andrade Perez, M. Tapias, A. Vera Torres 031 Mechanisms of resistance to EGFR tyrosine kinase inhibitor therapy in lung adenocarci- nomas Máté Mihálffy, Hungary E. Tóth, L. Báthory-Fülöp 032 Novel NTRK2 gene rearrangement in CNS neoplasia: pitfall or new finding? Denise Morotti, Italy E. Antelmi, A. Bettini, E. Costi, G. Ghirardi, M. Iascone, S. Intagliata, C. Lucca, R. Merli, M. Motta, R. Muni, G. Pezzetti, E. Rigoli, M. Sicignano, A. Gianatti